(1A.ALPHA.,7.ALPHA.,3.BETA.,B.ALPHA.)-1A,2,3,11B-TETRAHYDROBENZ(5,6)ANTHRA(1,2-B)OXIRENE-2,3-DIOL
UNII 9YX4AAR6J8
Substance Identification & Data
This profile provides standardized clinical and technical data for (1a.alpha.,7.alpha.,3.beta.,b.alpha.)-1a,2,3,11b-tetrahydrobenz(5,6)anthra(1,2-b)oxirene-2,3-diol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9YX4AAR6J8.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 63493-02-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C18H14O3 HZDVGGXATJSVKB-VSZNYVQBSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (1a.alpha.,7.alpha.,3.beta.,b.alpha.)-1a,2,3,11b-tetrahydrobenz(5,6)anthra(1,2-b)oxirene-2,3-diol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.